title: 2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
authors.affiliation: Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India.
authors.forename: Durga Prasanna
authors.identifier: 0000-0002-5035-7396
authors.initials: DP
authors.lastname: Misra
authors.affiliation: Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India.
authors.forename: Vikas
authors.initials: V
authors.lastname: Agarwal
authors.affiliation: Cinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: Aman
authors.initials: A
authors.lastname: Sharma
authors.affiliation: Department of Rheumatology, King George's Medical University, Lucknow, India.
authors.forename: Anupam
authors.initials: A
authors.lastname: Wakhlu
authors.affiliation: Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
authors.forename: Vir Singh
authors.initials: VS
authors.lastname: Negi
mesh_terms: D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid; D001688:Biological Products; D003906:Developing Countries; D006801:Humans; D014601:Utopias
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products
keywords: DMARDs (biologic); DMARDs (synthetic); Rheumatoid Arthritis